{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:53:12Z","timestamp":1781671992143,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.gore.2026.102132","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:48:44Z","timestamp":1780674524000},"page":"102132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Improvement in chronic lymphedema in a gynecologic cancer survivor after starting GLP-1 receptor agonist therapy: A case report"],"prefix":"10.1016","volume":"65","author":[{"given":"Andrea","family":"Fromson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody C.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subha","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gore.2026.102132_bb0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10585-023-10232-8","article-title":"Etiology and treatment of cancer-related secondary lymphedema","volume":"41","author":"Bernas","year":"2023","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.gore.2026.102132_bb0010","article-title":"The impact of cancer-related lower extremity lymphedema on patient quality of life: a qualitative meta-synthesis","volume":"5","author":"Bowman","year":"2023","journal-title":"J. Psychosocial Oncol. Res. Pract."},{"issue":"2","key":"10.1016\/j.gore.2026.102132_bb0015","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000009866","article-title":"The vicious circle of stasis, inflammation, and fibrosis in lymphedema","volume":"151","author":"Brown","year":"2022","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.gore.2026.102132_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1457363","article-title":"Glucagon-like peptide-1 receptor agonists (GLP-1 RAS) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)","volume":"15","author":"Brown","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.gore.2026.102132_bb0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3747\/co.27.7225","article-title":"Cancer-related lymphedema: clinical pearls for providers","volume":"27","author":"Chaput","year":"2020","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.gore.2026.102132_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1392375","article-title":"GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report","volume":"14","author":"Crowley","year":"2024","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2026.102132_bb0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/ijgc-2019-001032","article-title":"Lower extremity lymphedema in patients with gynecologic malignancies","volume":"30","author":"Dessources","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.gore.2026.102132_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-physiol-022516-034008","article-title":"Lymphatic dysfunction, leukotrienes, and lymphedema","volume":"80","author":"Jiang","year":"2018","journal-title":"Annu. Rev. Physiol."},{"issue":"11","key":"10.1016\/j.gore.2026.102132_bb0045","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11920-024-01543-y","article-title":"Cancer-related lymphedema and psychological distress","volume":"26","author":"Lau","year":"2024","journal-title":"Curr. Psychiatry Rep."},{"issue":"10","key":"10.1016\/j.gore.2026.102132_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-024-02441-2","article-title":"Incidence of lymphedema related to various cancers","volume":"41","author":"Letellier","year":"2024","journal-title":"Med. Oncol."},{"issue":"9","key":"10.1016\/j.gore.2026.102132_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102834","article-title":"Semaglutide and cancer: a systematic review and meta-analysis","volume":"17","author":"Nagendra","year":"2023","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"7","key":"10.1016\/j.gore.2026.102132_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158408","article-title":"Novel mechanisms of compromised lymphatic endothelial cell homeostasis in obesity: The role of leptin in lymphatic endothelial cell tube formation and proliferation","volume":"11","author":"Sato","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.gore.2026.102132_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000438","article-title":"Adiponectin\u2010mediated modulation of Lymphatic Vessel Formation and lymphedema","volume":"2","author":"Shimizu","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.gore.2026.102132_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108899","article-title":"Effect of glucagon-like peptide-1 receptor agonists on circulating levels of leptin and Resistin: a meta-analysis of randomized controlled trials","volume":"177","author":"Simental-Mend\u00eda","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.gore.2026.102132_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.REO.0000000000000096","article-title":"Validation of the lymphedema life impact scale version 2: a condition-specific measurement tool for persons with lymphedema","volume":"36","author":"Weiss","year":"2018","journal-title":"Rehabilit. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:07:46Z","timestamp":1781669266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578926001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":15,"alternative-id":["S2352578926001128"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2026.102132","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement in chronic lymphedema in a gynecologic cancer survivor after starting GLP-1 receptor agonist therapy: A case report","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2026.102132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102132"}}